N
PDSB icon

Nuveen’s PDS Biotechnology PDSB Stock Holding History

Nuveen’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,296
Closed -$437K – 3395
2024
Q1 		$437K Buy
110,296
+5,095
+5% +$26.2K ﹤0.01% 3015
2023
Q4 		$523K Hold
105,201
– – ﹤0.01% 2986
2023
Q3 		$531K Hold
105,201
– – ﹤0.01% 2831
2023
Q2 		$529K Buy
+105,201
New +$689K ﹤0.01% 2905

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's PDSB Position: Q2 2024 in Review

Nuveen sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 110,296 shares — an estimated $437K sold.

Nuveen first reported a position in PDSB in Q2 2023 and held it in 4 quarters. The position peaked at $531K in Q3 2023. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • Nuveen reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 110,296 PDS Biotechnology shares in Q2 2024, an estimated $437K.
  • Nuveen first reported a position in PDS Biotechnology in Q2 2023 and held it in 4 quarters.
  • Nuveen's PDS Biotechnology position peaked at $531K in Q3 2023.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.